ArticleClinical and translational science2026
Evaluation of Drug-Drug Interaction Potential Between the Oral Antibiotic Zoliflodacin and the CYP3A4 Inhibitor Itraconazole: A Phase 1 Study in Healthy Participants.
Alison Luckey et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.